Home > Drug Search >
  • company_query: AryoGen Biopharma
  •   > 
Drug Filter
Category:
chemistry (6) biology (29)
Status:
Approved (10) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (15) Phase Ⅰ (5)
Clinical Stage:
Pending (3) Active (18) Discontinued (4)
Bio-Type:
Vaccine (9) Allergen extract (7) Recombinant coagulation factor (1) Recombinant cytokines (1) Bispecific antibody (1) Whole antibody (3) Fab fragment (1) Fusion protein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute rejection in renal transplantation (1) Allergic rhinitis (AR) (6) Allergic rhinoconjunctivitis (6) Anemia (1) Bladder cancer (1) Breast cancer (1) Chronic myeloid leukemia (CML ) (2) Depression (1) HBV infection (1) Adult respiratory distress syndrome (ADRS) (1) HIV infection (1) Rabies (1) Juvenile rheumatoid arthritis (JRA) (1) Melanoma (2) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (2) Pancreatic cancer (2) Wegener's granulomatosis (1) Measles (1) Mumps (1) Rubella (1) Prostate cancer (1) Poliomyelitis (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Solid tumours (1) Peanut hypersensitivity (1) Type 2 diabetes (1) Colorectal cancer (3) Ankylosing Spondylitis (AS) (1) Microscopic polyangiitis (1) Acute Lung Injury (1) B-cell lymphoma (1) Type 1 diabetes (2) Hemophilia A (1) Hemophilia B (1) Congenital factor VII deficiency (1) Glanzmann’s thrombasthenia (1) Spinal cord injury (1) Peritoneum cancer (1) Brain injury (1) Graft versus host disease (1) Plaque psoriasis (2) Allergic asthma (1) Abdominal aortic aneurysm (1) Skin disorders (1) Cachexia (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top